PFE · News · 20260922N
Liquidity and Debt Position
PFIZER INC · 2026-09-22 · Importance 25 · Surprise 6
Pfizer’s leverage ratio was reported at 2.7x. The leverage level and patent-expiry risks through fiscal 2028 were cited as constraints on dividend increases. Planned cost savings are expected to support deleveraging through 2029.